Answer
Yes, peripheral neuropathy is a recognised adverse reaction to lorlatinib.
Sources for this answer
- Lorviqua 25 mg film coated tablets,Pfizer Limited · emc · SmPC §4.8 Undesirable effects · Version 14Document updated
Sources checked
loading page…
Sources checked
Explore the tools and reference material available on iatroX.
Explore askiatroX